China (Mainland)
Sarpogrelate Hydrochloride CAS NO.135159-51-2
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Sarpogrelate Hydrochloride
- Butanedioic acid
- 135159-51-2
Quick Details
- ProName: Sarpogrelate Hydrochloride
- CasNo: 135159-51-2
- Molecular Formula: C24H32ClNO6
- Appearance: White Crystalline Powder
- Application: Pharmaceutical intermediates
- DeliveryTime: Within three or five working days
- PackAge: 1kg/bag,seald package or at customer r...
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.9%
- Storage: Sealed container
- Transportation: Sealed container at cool&dry place
- LimitNum: 1 Kilogram
- Heavy Metal: Not detected
- Valid Period: 2020-12-15
Superiority
1. Advanced Factory Building and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
Sarpogrelate hydrochloride is a selective SR-2A antagonist (pKi values are 8.52, 7.43 and 6.57 for SR-2A, SR-2C and SR-2B,
respectively). Sarpogrelate hydrochloride has been shown to display selectivity over SR-1, SR-3, SR-4 H1, H2, M3, α1-adrenergic,
α2-adrenergic and β-adrenergic receptors. It also displays cardioprotective activity in vivo.
Specification
|
Analysis Test |
Specification |
Result |
|
Description |
white crystalline powder |
Conforms |
|
Solubility |
Easily soluble in water, unsoluble in ethanol |
Conforms |
|
PH |
6.0~7.5 |
6.9 |
|
Solution clarity and color |
solution should be clear and colorless |
Conforms |
|
Related substances |
5’CMP 0.3% Simple impurity Total other impurity |
0.01% 0.03% 0.10% |
|
Chloride |
0.05% |
Conforms |
|
Ammonium |
0.05% |
Conforms |
|
Fe |
0.01% |
Conforms |
|
Phosphate |
0.1% |
Conforms |
|
Loss on drying |
≤6.0% |
1.3% |
|
Heavy metals |
0.002% |
Conforms |
|
Arsenide |
0.0001% |
Conforms |
|
Bacterial Endotoxins |
0.3EU/mg |
Conforms |
|
Microbial Limit |
Conforms |
Conforms |
|
Assay(on dried basis) |
≥98.0% |
98.8% |
|
Conclusion: The results conform with CP2013 |
||
